PETV Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 21:57):

Stats
Dagens volum	17 848.00
Gjennomsnittsvolum	52 379.00
Markedsverdi	13.92M
EPS	$0 ( 2024-02-12 )
Neste inntjeningsdato	( $0 ) 2024-06-27
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.980
ATR14	$0.0320 (3.86%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-15	Lai John	Buy	150 000	Common Stock
2024-04-01	Lowenthal Garry N	Buy	90 000	Restricted Stock Units
2024-03-08	Lowenthal Garry N	Buy	0
2023-12-29	Martin James Rudolph	Buy	33 898	Stock Option (right to buy)
2023-12-29	Rudelius Robert James	Buy	31 780	Stock Option (right to buy)

INSIDER POWER
-99.80
Last 95 transactions
Buy: 994 862 \| Sell: 633 405 592

PetVivo Holdings, Inc. Korrelasjon

10 Mest positive korrelasjoner
HCAT	0.868
SDC	0.854
SAGE	0.834
SFST	0.82
CULL	0.817
PDCO	0.817
RNDV	0.816
BSBK	0.814
BOTJ	0.81
SHCR	0.805

10 Mest negative korrelasjoner
XOG	-0.848
IMCC	-0.832
EPSN	-0.826
EZFL	-0.824
COMT	-0.803
ENER	-0.803
LAUR	-0.802
FISV	-0.801
PDBC	-0.801

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

PetVivo Holdings, Inc. Økonomi

Annual	2023
Omsetning:	$917 162
Bruttogevinst:	$390 345 (42.56 %)
EPS:	$-0.850

FY	2023
Omsetning:	$917 162
Bruttogevinst:	$390 345 (42.56 %)
EPS:	$-0.850

FY	2022
Omsetning:	$115 586
Bruttogevinst:	$-85 568.00 (-74.03 %)
EPS:	$-0.560

FY	2021
Omsetning:	$12 578.00
Bruttogevinst:	$1 883.00 (14.97 %)
EPS:	$-0.570

Financial Reports:

No articles found.

PetVivo Holdings, Inc.

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.